Antiviral activity of caspase inhibitors: effect on picornaviral 2A proteinase

FEBS Lett. 2004 Feb 27;560(1-3):51-5. doi: 10.1016/S0014-5793(04)00069-9.


Peptide-based fluoromethyl ketones have been considered for many years to be highly specific caspase inhibitors distinctly blocking the progress of apoptosis in a variety of systems. Here we demonstrate that these compounds can significantly reduce rhinovirus multiplication in cell culture. In their methylated forms they block eIF4GI cleavage in vivo and in vitro and inhibit the activity of picornaviral 2A proteinases.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Antiviral Agents / metabolism*
  • Antiviral Agents / therapeutic use
  • Apoptosis
  • Caspase Inhibitors*
  • Endopeptidases / metabolism*
  • Eukaryotic Initiation Factor-4G
  • HeLa Cells
  • Humans
  • Peptide Fragments / metabolism
  • Peptide Initiation Factors / metabolism
  • Picornaviridae Infections / drug therapy*
  • Protein Processing, Post-Translational
  • RNA, Viral / metabolism
  • Rhinovirus / enzymology*
  • Rhinovirus / genetics
  • Time Factors


  • Antiviral Agents
  • Caspase Inhibitors
  • EIF4G1 protein, human
  • Eukaryotic Initiation Factor-4G
  • Peptide Fragments
  • Peptide Initiation Factors
  • RNA, Viral
  • Endopeptidases